4 ovarian cancer candidates to watch: GSK, Allarity and more

Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, OSE Immunotherapies and others are advancing their own candidates.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top